News

 

 

U.S. FDA Approves increased Compassionate Use Patient Cases and Sites for ReCell® in Life-Threatening Injuries

U.S. FDA Approves increased Compassionate Use Patient Cases and Sites for ReCell® in Life-Threatening Injuries • Up to 48 patients can now be treated at 15 US burnscenters • Increased...

Read more about U.S. FDA Approves increased Compassionate Use Patient Cases and Sites for ReCell® in Life-Threatening Injuries

Avita Medical to Participate in the 3rd annual Biotech and Money / Medtech and Money London 2017 Conference

Northridge, CA, Perth, Australia and London, United Kingdom – 25 January 2017 – link here.

Read more about Avita Medical to Participate in the 3rd annual Biotech and Money / Medtech and Money London 2017 Conference

BioScience Managers partners with large UK Venture Capital Trust Fund

Monsoon Communications 13 December 2016

Leading life sciences investment group BioScience Managers has partnered with London based investment firm Downing LLP to offer a new Healthcare Share Class to VCT investors.

Read more about BioScience Managers partners with large UK Venture Capital Trust Fund

BioScience Managers Translation Fund to spur Australian jobs and innovation

Monsoon Communications 13 December 2016

BioScience Managers, one of Australia’s leading life sciences investment firms, has been awarded a $100 million investment licence for the Federal Government-backed Biomedical Translation Fund.

Read more about BioScience Managers Translation Fund to spur Australian jobs and innovation

$500 million fund will help build Australia's biomedical industry of the future

The Hon Greg Hunt MP.  Media Release. 13 December 2016.

The Turnbull Government is today launching the $500 million Biomedical Translation Fund, established under the government’s National Innovation and Science Agenda, which will help take Australian biomedical discoveries out of the laboratory and to the patient.

 

Read more about $500 million fund will help build Australia's biomedical industry of the future

Nexvet Announces Initiation of Pivotal Efficacy Study of Frunevetmab in Cats

12 December 2016

Read more about Nexvet Announces Initiation of Pivotal Efficacy Study of Frunevetmab in Cats

New Data Gives Adherium Fuel To Accelerate Digital Tech Adoption in Drug Sector

19 November 2016

Read more about New Data Gives Adherium Fuel To Accelerate Digital Tech Adoption in Drug Sector

AmpliPhi Biosciences Announces Favorable Topline Safety and Tolerability Results from Its Phase 1 Trial in Patients with Chronic Rhinosinusitis

Tuesday October 25, 2016 

Read more about AmpliPhi Biosciences Announces Favorable Topline Safety and Tolerability Results from Its Phase 1 Trial in Patients with Chronic Rhinosinusitis

REX Stroke and Brain Injury Clinical Trial in Australia

Monday 24 October 2016

Read more about REX Stroke and Brain Injury Clinical Trial in Australia

BioScience to lure big super - The Australian

Sarah-Jane Tasker - The Australian October 13, 2016

Read more about BioScience to lure big super - The Australian

1 2 3 4 5 ... 22